Is cerebral cortical atrophy serious?
Cerebral cortical atrophy is generally considered quite serious and may lead to cognitive impairment and reduced intellectual function. Appropriate treatment methods should be selected based on the underlying causes. Specific details are as follows:
Cerebral cortical atrophy may occur with aging, as brain cells gradually decrease and cerebral cortex function becomes impaired, often resulting in a reduction in brain volume. This can lead to symptoms such as slowed reactions and memory decline. This condition is a normal physiological phenomenon and can be treated under medical guidance with medications such as acetylcholinesterase inhibitors or Aricept (donepezil) tablets.
Cerebral cortical atrophy may also be associated with long-term diabetes. High blood glucose levels increase blood viscosity and impair circulation, leading to chronic insufficient blood and oxygen supply to the brain. This commonly results in memory loss and cognitive dysfunction. Under medical supervision, antidiabetic drugs and brain cell activators—such as metformin tablets and Piracetam (Cerebrolysin) tablets—may be used for treatment. Long-standing hypertension, if not effectively controlled, can lead to cerebral arteriosclerosis, thereby impairing adequate blood and oxygen supply to the brain and contributing to cerebral cortical atrophy. In such cases, angiotensin-converting enzyme (ACE) inhibitors—such as enalapril maleate tablets or lisinopril tablets—may be prescribed under medical guidance.
In addition, cerebral cortical atrophy may be caused by brain tumors. A thorough medical evaluation at a hospital is necessary to determine the exact cause and select an appropriate treatment approach.